SCHEMBL13198568

SCHEMBL13198568

CCCn1c(-c2ccc(NC(=O)OCC)cc2)c(C#N)c2ccc(OCc3ccccc3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ADORA2B P29275 3/20 0.43
ADORA2A P29274 2/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ADORA3 P0DMS8 1/20 0.42
ADORA1 P30542 1/20 0.42
AS3MT Q9HBK9 1/20 0.42
HPGD P15428 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MAPT P10636 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10096339 0.91 ALDH1A1 (0.44) ALDH1A1MEN1KMT2APOLBMAPK1
SCHEMBL13214446 0.87 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AADORA2BADORA2A
SCHEMBL10095796 0.87 MTNR1B (0.44) ALDH1A1MEN1KMT2APOLBMAPK1
SCHEMBL10096221 0.87 AS3MT (0.47) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL10096332 0.85 ALDH1A1 (0.41) ALDH1A1MEN1KMT2APOLBMAPK1
SCHEMBL10096348 0.84 MEN1 (0.41) ALDH1A1MEN1KMT2APOLBMAPK1
SCHEMBL10096219 0.84 AR (0.51) ADORA2BADORA2ARAB9ANPC1SMN1; SMN2
SCHEMBL10096220 0.84 AR (0.53) MEN1KMT2AADORA2BADORA2ARAB9A
SCHEMBL10096338 0.83 L3MBTL1 (0.40) ALDH1A1MEN1KMT2APOLBMAPK1
SCHEMBL10096222 0.83 AR (0.49) ADORA2BADORA2ARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781478-B2 Methods for treating hepatitis C PTC THERAPEUTICS, INC. (US) 2010-08-24 US disclosed